Search Results - "clinical pharmacology"

COMMENTS ON THE ARTICLE BY M.M. SADYKOV, L.S. GRISHINA, R.R. NIYAZOV, L.YE. ZIGANSHINA «CLINICAL PHARMACOLOGICAL SERVICE IN OPTIMIZATION OF THE PHARMACOLOGICAL SUPPORT AT THE INITIAL STAGE OF THE PEDIATRIC CARE» by A.S. Kolbin

Connect to this object online.

COMMENTS ON THE ARTICLE BY M.M. SADYKOV, L.S. GRISHINA, R.R. NIYAZOV, L.YE. ZIGANSHINA «CLINICAL PHARMACOLOGICAL SERVICE IN OPTIMIZATION OF THE PHARMACOLOGICAL SUPPORT AT THE INITIAL STAGE OF THE PEDIATRIC CARE» by A.S. Kolbin

Connect to this object online.

Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease by Aaron Koenig, Michael Lewis, Jeff Wald, Sigui Li, Mustafa Varoglu, Jing Dai, Abdul Sankoh, Katrina Paumier, James Doherty, Mike Quirk

Connect to this object online.

Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration by Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea

Connect to this object online.

Role of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented or Suspected Gram-Negative Infections by Milo Gatti, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico Pea

Connect to this object online.

Gut bacterial microbiome composition and statin intake-A systematic review by Andreia M. Dias, Gonçalo Cordeiro, Maria M. Estevinho, Rui Veiga, Luis Figueira, Marta Reina‐Couto, Fernando Magro, the Clinical Pharmacology Unit, São João Hospital University Centre

Connect to this object online.

Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing by Akinyemi Oni‐Orisan, Nithya Srinivas, Krina Mehta, Jesmin Lohy Das, Thu T. Nguyen, Geoffrey H. Tison, Scott R. Bauer, Maria Burian, Ryan S. Funk, Richard A. Graham, Biomarkers and Translational Tools Community Working Group of the American Society for Clinical Pharmacology and Therapeutics

Connect to this object online.

Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers by Prothon S, Wählby Hamrén U, Tehler U, Yoon E, Forsman H, Arfvidsson C, Aggarwal A, Chen Y

Connect to this object online.

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter] by Liao MZ, Kast J, Berkhout M, Prenen H, Dutta S, Upreti VV

Connect to this object online.

An account on the history of pharmacology in Spain by Ana María Aldea-Perona, Jesús Flórez Beledo, Jesús Frías Iniesta, Antonio G. García, Juan Tamargo, Francisco Zaragozá

Connect to this object online.

Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter] by Montrasio C, Cheli S, Clementi E

Connect to this object online.

Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator Velsecorat (AZD7594) Following Inhalation in Healthy Volunteers by Prothon S, Aurivillius M, Tehler U, Eriksson UG, Aggarwal A, Chen Y

Connect to this object online.

Administration of Supplemental L-Tyrosine with Phenelzine: A Clinical Literature Review [Expression of Concern] by Hinz M, Stein A, Cole T, Ryan P

Connect to this object online.

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern] by Hinz M, Stein A, Cole T

Connect to this object online.

Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects by Hwang S, Lee DY, Cho JY, Chung JY, Jang IJ, Yu KS, Lee S

Connect to this object online.

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum] by Lozano R, Domeque N, Apesteguia AF

Connect to this object online.

Glucocorticoids Do Not Affect the Vascular Component of TRP-Mediated Neurogenic Skin Inflammation by Marynissen H, de Hoon J

Connect to this object online.

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum] by Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C

Connect to this object online.

ASSESSMENT OF EFFICIENCY OF USING MEDICATIONS IN CHILDREN ON THE MODEL OF ANTIPYRETICS IN AN OUTPATIENT ADMINISTRATION SETTING by L.S. Grishina, M.M. Sadykov, L.Е. Ziganshina

Connect to this object online.

ASSESSMENT OF EFFICIENCY OF USING MEDICATIONS IN CHILDREN ON THE MODEL OF ANTIPYRETICS IN AN OUTPATIENT ADMINISTRATION SETTING by L.S. Grishina, M.M. Sadykov, L.Е. Ziganshina

Connect to this object online.